Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Hematopoietic stem cell transplantation Stories

2014-04-18 23:03:46

NewYork-Presbyterian/Columbia University Medical Center has opened the Irving Bone Marrow Transplant Unit, a state-of-the-art facility for comprehensive bone marrow transplant (BMT) care. The new unit features 18 inpatient rooms, a high-tech nurses station for individual patient monitoring, and a specialized airflow system to help protect patients with weakened immune systems. New York, NY (PRWEB) April 18, 2014 Irving Bone Marrow Transplant Unit Opens at NewYork-Presbyterian/Columbia...

2014-04-14 23:05:32

Matt Jones went from being a three time cancer conqueror to relearning how to walk to running five marathons on five continents and is now a life changing inspirational and motivational leadership speaker. April 14th marks his ten year anniversary of a bone marrow transplant. To celebrate he is giving away his book, "Cancer is a Marathon." Austin, TX (PRWEB) April 14, 2014 More than 1 in 3 people will develop some form of cancer during their lifetime (American Cancer Society)....

2014-04-14 04:20:35

Bank's donation brings Canadian Blood Services another step closer to meeting growing demand for stem cells in Canada OTTAWA, April 14, 2014 /CNW/ - A life-saving national public stem cell bank will soon become a reality thanks to a generous $300,000 donation from CIBC. The donation will support Canadian Blood Services' Campaign For All Canadians, helping to raise funds towards the establishment of a national public cord blood bank in Canada. The demand for blood stem cells in...

2014-04-11 12:23:51

DUBLIN, Apr. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qsm3wn/cord_blood ) has announced the addition of the "Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Stem cells are capable of producing all the three types of blood cells produced in human body i.e. red blood cells, platelets and white...

2014-04-08 08:30:19

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation. "Initiation of...

2014-04-07 08:30:00

Phase I Demonstrates Quizartinib Tolerability in Combination with Chemotherapy SAN DIEGO, April 7, 2014 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the Phase 2 cohort of the MD Anderson Cancer Center-sponsored Phase 1/2 study of quizartinib in combination with either 5-azacitidine or low dose...

2014-04-07 08:29:57

PRINCETON, N.J., April 7, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Dental and Craniofacial Research (NIDCR) has awarded Soligenix a Small Business Innovation Research (SBIR) grant...

2014-03-31 12:10:17

Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, researchers report. Using microarray technology that probes millions of genes within chromosomes, researchers found the unique pattern in the leukemia cells of 22 patients diagnosed with cytogenetically normal acute myelogenous leukemia, said Dr. Ravindra Kolhe,...

2014-03-31 08:29:52

Defitelio®? (defibrotide) Launch Announced During the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) 2014 DUBLIN and VILLA GUARDIA, Italy, March 31, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Gentium S.p.A., a Jazz Pharmaceuticals company, today announced the commencement of the European commercial launch of Defitelio®(?) (defibrotide), the first licensed product for the treatment of severe hepatic veno-occlusive...

2014-03-27 08:35:22

25% of all the stem cell units released for use by CBR have been collected under their free access initiative SAN BRUNO, Calif., March 27, 2014 /PRNewswire/ -- Stem cells derived from cord blood are a treatment option for families affected by certain types of cancer, immune system disorders, and genetic diseases. Yet, the overwhelming majority of families are not storing cord blood for family use or donating to a public bank due to a lack of awareness regarding the medical...


Latest Hematopoietic stem cell transplantation Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »